TITLE

The Multiple Faces of Glucagon-Like Peptide-1—Obesity, Appetite, and Stress: What Is Next? A Review

AUTHOR(S)
Eldo Frezza; Mitchell Wachtel; Maurizio Chiriva-Internati
PUB. DATE
March 2007
SOURCE
Digestive Diseases & Sciences;Mar2007, Vol. 52 Issue 3, p643
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract??By itself, glucagon-like peptide-1(GLP-1) appears to be an excellent drug for appetite control and the treatment of obesity. Unfortunately, few enzymes, such as IV dipeptidyl peptidase and renal excretin, degrade and render GLP-1 inactive within minutes. A receptor agonist, exendin-4, with a longer biological half-life than GLP-1, has been tried. Subcutaneous injection of exendin-4 or continuous IV injection of GLP-1 warrants further research and investigation.
ACCESSION #
24079656

 

Related Articles

  • A Time to Heal. Cabrera, Dena // Arizona Foothills Magazine;Feb2011, p44 

    The article offers information on Remuda Ranch, a treatment center for girls and women with eating disorders, in Wickenburg, Arizona. The ranch's approach focuses on individual recovery by engaging each patient with bulimia and anorexia in various individual and group therapies and innovative...

  • NUTRITION.  // MPR - Residents' Edition;Fall/Winter2010, Vol. 19 Issue 2, p174 

    The article offers information on several approved nutritional supplements. Feosol, an iron supplement from GlaxoSmithKline, is used in alleviating iron deficiency and anemia. Xenical, a lipase inhibitor from Roche, is used as an aid in reducing calorie intake. Megace Oral Suspension from...

  • SECTION 12: NUTRITION.  // MPR - Residents' Edition;Fall/Winter2011, Vol. 20 Issue 2, p160 

    The article offers prescribing notes for hematinics, obesity and anorexia including information on the name of the product, indications and contraindications in the U.S. Nascobal from Strativa Pharmaceuticals maintains hematologic remission after vitamin B12 therapy. Xenical from F. Hoffmann-La...

  • Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial. Navari, Rudolph; Brenner, Marie // Supportive Care in Cancer;Aug2010, Vol. 18 Issue 8, p951 

    The purpose of the study was to determine the effectiveness of megestrol acetate (MA) and olanzapine (OLN) for the treatment of cancer-related anorexia (CRA). Eighty adult patients with advanced gastrointestinal cancer or lung cancer (stages III and IV) with CRA (loss of appetite and greater...

  • Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans. Stier, Heike; Vos, Evert; Kenley, David // Journal of Endocrinology & Metabolism;2013, Vol. 3 Issue 1/2, p7 

    Background: The human growth hormone (hGH) has properties making it a potential candidate to treat obesity, however safety issues limit its long-term use. AOD9604 is a peptide fragment of the C-terminus of hGH (Tyr-hGH177-191), which harbors the fat reducing activity of hGH, without its negative...

  • Is immediate-release topiramate an effective treatment for adult obesity? Harshman, Heather; Kovach, Fran // Journal of Family Practice;Dec2014, Vol. 63 Issue 12, p745 

    The article provides an answer to a question on how effective immediate-release topiramate can treat obesity in adults.

  • Intensive Psychotherapy of Former Anorexic Individuals. Bemporad, Jules R.; Ratey, John // American Journal of Psychotherapy;Oct1985, Vol. 39 Issue 4, p454 

    Reports on the intensive psychotherapy of six recovered anorexic female adults. Premorbid parental and familial interaction and particular difficulties surrounding the onset of the anorexic illness; Description of persistent personality problems, difficulties in relationships and characteristic...

  • Anorexia not just a 'girl' problem.  // Asian Pacific Post;8/14/2008, p18 

    The article presents findings of a survey on the number of men being treated for anorexia and eating disorders in Great Britain.

  • Novel use of L-DOPA in the treatment of anorexia and asthenia associated with cancer. Lozano, Ramon Herreros; Jofre, Irene Serrat // Palliative Medicine;Oct2002, Vol. 16 Issue 6, p548 

    Focuses on the novel use of L-DOPA in the treatment of anorexia and asthenia associated with cancer. Alleged improvement in anorexia patients.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics